Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study

Abstract

Aims Metabolic syndrome (MS) is a global health problem associated with an increased risk of diabetes mellitus (DM), cardiovascular disease (CVD), and cancer. Body composition parameters, including obesity, visceral adiposity, and sarcopenia contribute to the development of MS and CVD. Previous studies have investigated the association of individual body composition parameters with MS. Studies analyzing the association between multiple body composition parameters and MS have been rare. We aimed to investigate the association between MS and multiple body composition parameters, including obesity, visceral adiposity, and sarcopenia. Methods A total of 13,620 subjects who underwent voluntary routine checkups at the Health Care Center of our institution between October 2014 and December 2019 were enrolled. Only data from the first examination of subjects who underwent repeated checkups were included. Clinical and laboratory data were collected. Skeletal muscle mass and visceral fat area (VFA) were measured using bioelectrical impedance analysis. Appendicular skeletal muscle mass (ASM) was divided by body weight (in kg) and expressed as a percentage (calculated as, ASM% = ASM × 100/Weight). Data were compared between the groups based on obesity, VFA, and ASM%. Logistic regression analysis was performed to determine the risk of MS in each group. Results Body mass index and VFA were significantly higher in subjects with MS than in those without MS. ASM% was significantly lower in subjects with MS than in those without MS. Subjects with obesity, visceral adiposity, or sarcopenia had a higher prevalence of MS than those without. As the number of metabolic components increased from 0 to 5, we identified a decreasing trend of ASM% and an increasing trend of VFA and BMI (P for trend < 0.001 for all). In the paired analyses, all the three body composition parameters showed additive effects in predicting MS. In the logistic regression analysis, the three parameters were associated with an increased risk of MS after adjustment for age, sex, hypertension, DM, dyslipidemia, smoking, alcohol intake, and C-reactive protein. Conclusions Obesity, visceral adiposity, and sarcopenia showed additive effects on MS prediction. Subjects with obesity, visceral adiposity, or sarcopenia were significantly associated with the increased risk of MS after adjustment for multiple confounders. Increasing skeletal muscle and reducing visceral fat may be strategies for the prevention or treatment of MS.

Effects of Omega-3 Supplementation Alone and Combined with Resistance Exercise on Skeletal Muscle in Older Adults: A Systematic Review and Meta-Analysis

“…This cost has undoubtedly risen even more due to the aging population, and it is suggested that more high-quality research utilizing cost-effective strategies to counteract these effects is warranted [ 3 ]. Further, several scientific studies have demonstrated the association of sarcopenia with metabolic function and inflammation [ 4 , 5 , 6 , 7 , 8 ]. Chronic low-grade inflammation associated with aging (i.e., ‘inflammaging’) is known to precipitate metabolic syndrome, which may have a reciprocal function in perpetuating the ‘inflammaging’, creating a vicious cycle leading to skeletal muscle mass loss due to the catabolic activity of pro-inflammatory mediators [ 9 ].…”

Emerging functions of circular RNA in the regulation of adipocyte metabolism and obesity

“…It participates in a variety of physiological processes and is of great significance to the life activities of the body. Abnormal adipocyte metabolism and metabolic disorders have become epidemics in various countries around the world [ 1 , 2 ], and can cause metabolic syndromes, including obesity, hepatic steatosis, adipose tissue dysfunction, atherosclerosis, and type 2 diabetes [ 3 , 4 ]. Studies have shown that peroxisome proliferator-activated receptor γ (PPARγ) [ 5 ], CCAAT/enhancer-binding protein (C/EBPα) [ 6 ], and the sterol regulatory element-binding protein (SREBP) family [ 7 ] participate in the adipocyte metabolism regulation.…”

The correlation between visceral fat area to skeletal muscle mass ratio and multi-organ insulin resistance in Chinese population with obesity: a cross-sectional study

“…In nearly a decade of research, we have observed that VFA is a more re ective indicator of physical health and cardiometabolic diseases as opposed to BMI, or waist-to-hip ratio [22,23] . Meanwhile, the accumulation of visceral fat was the major contributor to IR [24] .…”